Bogale Kassahun, Aderaw Assasu
Clinical Pharmacy Unit, Department of Pharmacy, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia.
Department of Pharmacy, Wollo University, Dessie, Ethiopia.
Integr Blood Press Control. 2021 Jan 22;14:1-7. doi: 10.2147/IBPC.S268186. eCollection 2021.
Hypertension is a risk factor for heart, brain, kidney, and other diseases. It is also the major cause of premature death. Thus, it is important to prevent, treat, and control hypertension and to reduce the risk of cardiovascular disease.
To determine the level of blood pressure control and associated factors based on the new intensive blood pressure goals (<130/80 mmHg).
A cross-sectional study design was used to assess the level of blood pressure control and associated factors from February 15 to April 15, 2019. Two hundred and sixteen patients were selected through a systematic sampling technique.
From 203 hypertension patients incorporated in the study, 102 (50.2%) were females. The mean age of patients documented during the last date of follow-up was 55.2 (SD=±14.47). About 51.2% of patients were less than 5 years from the day of diagnosis of hypertension. The majority of the study participants (111, 54.7%) were using two antihypertensives. The most common anti-hypertensive medication was hydrochlorothiazide (HCT), at 25 (12.3%). The most common combination drug therapy used was the combination of HCT and calcium channel blockers, at 62 (30.5%). Heart failure (22, 20.8%), stroke (18, 16.98%), and dyslipidemia (17, 16.04%) were the top three comorbidities. Based on the new intensive targets of blood pressure control (<130/80 mmHg), the blood pressure was controlled for only 25 (12%) patients.
The level of blood pressure control for hypertensive patients on chronic follow-up at Dessie Referral Hospital was very poor.
高血压是心脏、大脑、肾脏及其他疾病的危险因素。它也是过早死亡的主要原因。因此,预防、治疗和控制高血压以及降低心血管疾病风险非常重要。
根据新的强化血压目标(<130/80 mmHg)确定血压控制水平及相关因素。
采用横断面研究设计,于2019年2月15日至4月15日评估血压控制水平及相关因素。通过系统抽样技术选取了216例患者。
纳入研究的203例高血压患者中,102例(50.2%)为女性。最后一次随访记录的患者平均年龄为55.2岁(标准差=±14.47)。约51.2%的患者自高血压诊断之日起不到5年。大多数研究参与者(111例,54.7%)使用两种抗高血压药物。最常用的抗高血压药物是氢氯噻嗪(HCT),占25例(12.3%)。最常用的联合药物治疗是HCT与钙通道阻滞剂的联合,占62例(30.5%)。心力衰竭(22例,20.8%)、中风(18例,16.98%)和血脂异常(17例,16.04%)是前三大合并症。根据新的强化血压控制目标(<130/80 mmHg),仅25例(12%)患者的血压得到控制。
德西转诊医院接受慢性随访的高血压患者血压控制水平非常差。